Literature DB >> 29513410

[Cytokine-inducing and anti-inflammatory activity of chitosan and its low-molecular derivative].

V N Davydova, A A Kalitnik, P A Markov, A V Volod'ko, S V Popov, I M Ermak.   

Abstract

A low-molecular derivative of the polysaccharide (5 kDa) was obtained and its cytokine-inducing and anti-inflammatory activity was studied by free radical depolymerization of chitosan (110 kDa). It was shown that high-molecular chitosan in vitro inhibited the synthesis of anti-inflammatory cytokine, the tumor necrosis factor alpha induced by endotoxin. In the case of peroral introduction to experimental animals, high- and low-molecular chitosans stimulated synthesis of the anti-inflammatory cytokine IL-10 in the blood serum of mice; in this case, the activity of the high-molecular derivative was two times higher as compared with the initial polysaccharide. With peroral introduction, the initial polysaccharide (50 mg/kg) and its derivative inhibited the development of chemically induced inflammation of experimental animals’ large intestines, which was manifested as a decrease in the affected area and the degree of damage to the large intestine wall, as well as a two-fold reduction of myeloperoxidase activity. According to morphological and biochemical characteristics, the effect of chitosans was similar to that of a hormone anti-inflammatory drug, prednisolone.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29513410

Source DB:  PubMed          Journal:  Prikl Biokhim Mikrobiol        ISSN: 0555-1099


  2 in total

Review 1.  Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties.

Authors:  Kieran Joyce; Georgina Targa Fabra; Yagmur Bozkurt; Abhay Pandit
Journal:  Signal Transduct Target Ther       Date:  2021-03-19

2.  Chitosan/PVA Hetero-Composite Hydrogel Containing Antimicrobials, Perfluorocarbon Nanoemulsions, and Growth Factor-Loaded Nanoparticles as a Multifunctional Dressing for Diabetic Wound Healing: Synthesis, Characterization, and In Vitro/In Vivo Evaluation.

Authors:  Yu-Hsiang Lee; Sheng-Jhe Lin
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.